Neuralink, Elon Musk’s brain-tech startup, has announced the launch of a groundbreaking feasibility study for its wireless brain-computer interface and experimental robotic arm. The study, approved by Health Canada and now expanding in the U.S., aims to empower patients with quadriplegia to control external devices using their thoughts.
The device, already implanted in two patients in the U.S., has showcased promising results. One patient has successfully played video games, browsed the internet, and controlled a laptop cursor using the implant. The second patient is reportedly learning to design 3D objects using similar capabilities.
“Canadian neurosurgeons, in collaboration with Neuralink, will recruit six patients with paralysis to participate in the trial,” the company stated on social media platform X. Cross-enrollment of participants from its ongoing PRIME trial is also underway, furthering its evaluation of safety and efficacy.
The FDA and Neuralink have yet to share more details on the U.S. feasibility study. With approvals in both the U.S. and Canada, this groundbreaking technology is poised to revolutionize neurorehabilitation, sparking global interest among healthcare professionals.
